We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
-4.33%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$420M
AUM Growth
+$69.1M
Cap. Flow
+$105M
Cap. Flow %
24.98%
Top 10 Hldgs %
47.86%
Holding
226
New
142
Increased
26
Reduced
23
Closed
35

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$23.7M
2
DHR icon
Danaher
DHR
+$22.7M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$22.1M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$18M
5
CCI icon
Crown Castle
CCI
+$17.5M

Top Sells

Rank Stock Value
1
MCK icon
McKesson
MCK
+$33.7M
2
ELV icon
Elevance Health
ELV
+$27.6M
3
KO icon
Coca-Cola
KO
+$25.4M
4
NVO
Novo Nordisk
NVO
+$25.3M
5
EOG icon
EOG Resources
EOG
+$23.5M

Sector Composition

Rank Sector Weight
1 Healthcare 32.16%
2 Technology 23.66%
3 Consumer Staples 13.55%
4 Financials 10.55%
5 Industrials 4.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.77T
$37.7M 8.98%
272,839
+24,945
+10% +$3.92M
UNH icon
2
UnitedHealth
UNH
$383B
$23.1M 5.5%
45,730
+45,050
+6,625% +$23.7M
BRK.B icon
3
Berkshire Hathaway Class B
BRK.B
$1.06T
$22.9M 5.44%
85,593
+77,525
+961% +$22.1M
DHR icon
4
Danaher
DHR
$143B
$21.2M 5.06%
+92,796
New +$22.7M
VRTX icon
5
Vertex Pharmaceuticals
VRTX
$123B
$18.1M 4.3%
+62,420
New +$18M
JNJ icon
6
Johnson & Johnson
JNJ
$604B
$18M 4.28%
110,046
+95,977
+682% +$16.2M
PEP icon
7
PepsiCo
PEP
$183B
$16.7M 3.99%
102,546
+100,646
+5,297% +$17.3M
CCI icon
8
Crown Castle
CCI
$34.2B
$14.8M 3.52%
+102,200
New +$17.5M
MA icon
9
Mastercard
MA
$482B
$14.5M 3.45%
51,024
+50,095
+5,392% +$16.6M
LLY icon
10
Eli Lilly
LLY
$1.04T
$14.1M 3.35%
43,574
+40,619
+1,375% +$12.9M
COST icon
11
Costco
COST
$416B
$13.9M 3.31%
29,450
+22,240
+308% +$11.6M
PG icon
12
Procter & Gamble
PG
$347B
$13.4M 3.19%
106,277
-147,844
-58% -$21M
MSFT icon
13
Microsoft
MSFT
$2.98T
$13.4M 3.19%
57,481
+46,659
+431% +$12.3M
ATO icon
14
Atmos Energy
ATO
$29.5B
$12.2M 2.91%
+119,950
New +$13.7M
PANW icon
15
Palo Alto Networks
PANW
$292B
$11.4M 2.73%
+139,800
New +$12.1M
ORCL icon
16
Oracle
ORCL
$352B
$10.7M 2.56%
+175,933
New +$12.9M
CP icon
17
Canadian Pacific Kansas City
CP
$82B
$9.09M 2.16%
+136,188
New +$10.3M
REGN icon
18
Regeneron Pharmaceuticals
REGN
$71.5B
$8.05M 1.92%
+11,690
New +$7.36M
QCOM icon
19
Qualcomm
QCOM
$181B
$7.59M 1.81%
+67,170
New +$9.23M
BG icon
20
Bunge Global
BG
$23.4B
$7.22M 1.72%
+87,500
New +$8.15M
TMO icon
21
Thermo Fisher Scientific
TMO
$197B
$6.26M 1.49%
12,347
+11,060
+859% +$6.19M
MRK icon
22
Merck
MRK
$310B
$6.07M 1.44%
70,450
+65,589
+1,349% +$5.86M
AVGO icon
23
Broadcom
AVGO
$1.81T
$5.92M 1.41%
133,300
+126,600
+1,890% +$6.47M
CMG icon
24
Chipotle Mexican Grill
CMG
$42.4B
$5.41M 1.29%
+180,000
New +$5.58M
V icon
25
Visa
V
$686B
$4.7M 1.12%
26,434
-89,981
-77% -$18.3M
1
2 3 4 5

Similar funds

ECA
Endeavour Capital Advisors Greenwich, Connecticut $441M AUM 21.38% 1-Year Est. Return
DWML
Decker Wealth Management LLC Nashville, Tennessee $441M AUM
BOA
Birnam Oak Advisors New York $441M AUM 37.12% 1-Year Est. Return
PLU
Performa Ltd (US) Charleston, South Carolina $442M AUM 13.84% 1-Year Est. Return
CPW
Cove Private Wealth Oyster Bay Cove, New York $440M AUM 27.56% 1-Year Est. Return
AWM
Austin Wealth Management Austin, Texas $440M AUM 17.66% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return

De Burlo Group's Q3 2022 Portfolio in Review

As of Q3 2022, De Burlo Group held 226 positions worth $420M, up 20% from $351M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

De Burlo Group deployed $105M of net new capital in Q3 2022, opening 142 new positions and adding to 26 existing holdings. Its largest new stake was Danaher: 92,796 shares worth $21.2M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 28% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Coca-Cola, an estimated $25.4M trimmed.

  • De Burlo Group's largest Q3 2022 buy was Danaher: 92,796 shares worth $21.2M.
  • De Burlo Group added most to UnitedHealth in Q3 2022, an estimated $23.7M increase.
  • De Burlo Group's biggest Q3 2022 reduction was Coca-Cola, cutting an estimated $25.4M.
  • De Burlo Group fully exited McKesson in Q3 2022, selling an estimated $33.7M.
  • De Burlo Group's ten largest holdings make up 48% of its $420M portfolio in Q3 2022.
  • De Burlo Group opened 142 new positions and closed 35 in Q3 2022.
  • De Burlo Group's portfolio value rose 20% quarter-over-quarter to $420M.

Based on De Burlo Group's 13F filing for Q3 2022, filed 14 Nov 2022.